60歳以上の高齢もやもや病患者に対する血行再建術-周術期過灌流に注目して-

文献

J-GLOBAL ID：201402218944118826 整理番号：14A0239288

Issues in Revascularization Surgery for Elderly Patients with Moyamoya Disease

出版者サイト {{ this.onShowPLink() }} 複写サービスで全文入手 {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=14A0239288&COPY=1") }}
高度な検索・分析はJDreamⅢで {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0239288&from=J-GLOBAL&jstjournalNo=X0801A") }}

著者 (7件)： , , , , , ,
資料名：
巻： 42 号： 1 ページ： 37-41 発行年： 2014年01月31日
JST資料番号： X0801A ISSN： 0914-5508 資料種別：逐次刊行物 (A)
記事区分：原著論文発行国：日本 (JPN) 言語：日本語 (JA)

もやもや病は両側内頚動脈終末部,前およびに中大脳動脈近位部が...

,...
,...

続きはJDreamIII（有料）にて {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0239288&from=J-GLOBAL&jstjournalNo=X0801A") }}

神経系疾患の外科療法

引用文献 (12件)：

1) Fujimura M, Kaneta T, Mugikura S, et al: Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67: 273-282, 2007
2) Fujimura M, Shimizu H, Mugikura S, et al: Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: Possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71: 223-227, 2009
3) Fujimura M, Mugikura S, Kaneta T, et al: Incidence and risk factors for symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71: 442-447, 2009
4) Fujimura M, Shimizu H, Inoue T, et al: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after EC-IC bypass for moyamoya disease: Comparative study with non-moyamoya patients using ¹²³I-IMP-SPECT. Neurosurgery 68: 957-965, 2011
5) Fujimura M, Inoue T, Shimizu H, et al: Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33: 436-445, 2012

, , , , ,

前のページに戻る